Actinium Pharmaceuticals Net Non-Operating Interest Income Expense (Quarterly) Analysis

Actinium Pharmaceuticals, Inc. (ATNM)

1.34 +0.02 (+1.52%) USD | NYAM | Jan 22, 16:00

1.34 0.00 (0.00%) After-Hours: 20:00

View Net Non-Operating Interest Income Expense (Quarterly) for ATNM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	Upgrade
Altimmune, Inc.	Upgrade
Aldeyra Therapeutics, Inc.	Upgrade
Avanos Medical, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade